Literature DB >> 2382271

Inorganic arsenic methylation by rat tissue slices.

B Georis1, A Cardenas, J P Buchet, R Lauwerys.   

Abstract

Rat liver, kidney and lung slices methylate trivalent inorganic arsenic (AsIII) to monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA); the liver has the greatest methylating capacity. AsIII enters the liver cells by a diffusion process followed by extensive binding to intracellular components which favors its extensive accumulation inside the cells. Reduced glutathione regulates AsIII metabolism through several mechanisms: facilitation of AsIII diffusion into the cells, stimulation of the first methylation reaction and increase of DMA excretion by the cells. An excess of AsIII inhibits DMA production by liver cells but this inhibition is reversible; mercuric ions inhibit both MMA and DMA production probably by decreasing inorganic arsenic (Asi) uptake and the second methylation reaction. DMA can be produced from MMA by rat liver slices and this methylation step is stimulated by GSH. In contrast to AsIII, AsV is not extensively taken up by the hepatocyte and is thus poorly methylated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2382271     DOI: 10.1016/0300-483x(90)90070-w

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  10 in total

1.  Glutathione S-transferase pi in an arsenic-resistant Chinese hamster ovary cell line.

Authors:  J F Lo; H F Wang; M F Tam; T C Lee
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

Review 2.  Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals.

Authors:  David J Thomas; Jiaxin Li; Stephen B Waters; Weibing Xing; Blakely M Adair; Zuzana Drobna; Vicenta Devesa; Miroslav Styblo
Journal:  Exp Biol Med (Maywood)       Date:  2007-01

3.  Metabolic profile and assessment of occupational arsenic exposure in copper- and steel-smelting workers in China.

Authors:  Shuhua Xi; Quanmei Zheng; Qiang Zhang; Guifan Sun
Journal:  Int Arch Occup Environ Health       Date:  2010-12-04       Impact factor: 3.015

4.  Relation between airborne arsenic trioxide and urinary excretion of inorganic arsenic and its methylated metabolites.

Authors:  J A Offergelt; H Roels; J P Buchet; M Boeckx; R Lauwerys
Journal:  Br J Ind Med       Date:  1992-06

5.  Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes--mechanistic insights and implications for further experiments.

Authors:  Michael R Easterling; Miroslav Styblo; Marina V Evans; Elaina M Kenyon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-06       Impact factor: 2.745

6.  Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites.

Authors:  Hisham A El-Masri; Elaina M Kenyon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-10-18       Impact factor: 2.745

7.  Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan.

Authors:  M M Wu; H Y Chiou; T W Wang; Y M Hsueh; I H Wang; C J Chen; T C Lee
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

8.  Site-specific data confirm arsenic exposure predicted by the U.S. Environmental Protection Agency.

Authors:  S Walker; S Griffin
Journal:  Environ Health Perspect       Date:  1998-03       Impact factor: 9.031

9.  Methylation study of a population environmentally exposed to arsenic in drinking water.

Authors:  C Hopenhayn-Rich; M L Biggs; A H Smith; D A Kalman; L E Moore
Journal:  Environ Health Perspect       Date:  1996-06       Impact factor: 9.031

10.  Arsenic increased lipid peroxidation in rat tissues by a mechanism independent of glutathione levels.

Authors:  O Ramos; L Carrizales; L Yáñez; J Mejía; L Batres; D Ortíz; F Díaz-Barriga
Journal:  Environ Health Perspect       Date:  1995-02       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.